The Journal of Pediatrics
Volume 156, Issue 1 , Pages 98-102.e1, January 2010

Pubertal Metformin Therapy to Reduce Total, Visceral, and Hepatic Adiposity

  • Lourdes Ibáñez, MD, PhD

      Affiliations

    • Endocrinology, Hospital Sant Joan de Déu, University of Barcelona, Barcelona, and CIBER de Diabetes y Enfermedades Metabólicas Asociadas, Barcelona, Spain
    • Corresponding Author InformationReprint requests: Lourdes Ibáñez, MD, PhD, Endocrinology Unit, Hospital Sant Joan de Déu, University of Barcelona, Passeig de Sant Joan de Déu, 2, 08950 Esplugues, Barcelona, Spain.
  • ,
  • Abel Lopez-Bermejo, MD, PhD

      Affiliations

    • Pediatric Endocrinology, Dr. Trueta Hospital, Girona, Spain
  • ,
  • Marta Diaz, MD, PhD

      Affiliations

    • Endocrinology, Hospital Sant Joan de Déu, University of Barcelona, Barcelona, and CIBER de Diabetes y Enfermedades Metabólicas Asociadas, Barcelona, Spain
  • ,
  • Maria Victoria Marcos, MD, PhD

      Affiliations

    • Endocrinology Unit, Hospital de Terrassa, Terrassa, Spain
  • ,
  • Francis de Zegher, MD, PhD

      Affiliations

    • Department of Woman & Child, University of Leuven, Leuven, Belgium

Received 1 March 2009; received in revised form 10 June 2009; accepted 6 July 2009. published online 23 September 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 L.I., M.D., and M.V.M. are Clinical Investigators of CIBERDEM (Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas, Instituto de Salud Carlos III, Madrid, Spain). A.L.B. is an Investigator of the Fund for Scientific Research I3 (Ministry of Education and Science, Spain). F.dZ. is a Clinical Investigator of the Fund for Scientific Research (Flanders, Belgium).

 The authors declare no conflicts of interest.

PII: S0022-3476(09)00645-3

doi:10.1016/j.jpeds.2009.07.012

The Journal of Pediatrics
Volume 156, Issue 1 , Pages 98-102.e1, January 2010